Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns 
Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target 
Dollar Near Two-Week High as Stock Rout, AI Concerns and Global Events Drive Market Volatility 
Silver Prices Plunge in Asian Trade as Dollar Strength Triggers Fresh Precious Metals Sell-Off 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
Trump’s Inflation Claims Clash With Voters’ Cost-of-Living Reality 
Asian Stocks Slip as Tech Rout Deepens, Japan Steadies Ahead of Election 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
Dow Hits 50,000 as U.S. Stocks Stage Strong Rebound Amid AI Volatility 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
Oil Prices Slide on US-Iran Talks, Dollar Strength and Profit-Taking Pressure 
Russian Stocks End Mixed as MOEX Index Closes Flat Amid Commodity Strength 
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
Vietnam’s Trade Surplus With US Jumps as Exports Surge and China Imports Hit Record 
Juul, an American electronic cigarette company, will be ordered by the U.S. Food and Drug Administration (FDA) to remove its products from the local market. The said federal agency will soon ban the sale of the company’s sweet and fruity e-cigarette cartridges in the country.
According to Fox Business, the FDA is now preparing to hand over its order for Juul Labs Inc. to pull out its e-cigarette products from the U.S. market, and this was revealed by sources who are familiar with the matter.
It was reported that the agency may announce its decision as early as any time this week. The possible order of ban follows an almost two-year data review that was presented by Juul that was seeking permission to continue the sale of its tobacco and menthol-flavored products in the U.S.
Since the company started to be monitored by the FDA four years ago, Juul’s future fell into uncertainty. This was because its trendy marketing for its fruity vapes was blamed for the surge of underage vaping. Since then, the company has done its best to earn the trust of the public and regulators once again.
Juul limited its marketing campaign, and it stopped the sale of fruity and sweet flavors in 2019. However, the company’s sales have been declining in recent years.
At any rate, while Juul is close to being banned in the market, its rivals such as NJOY Holdings Inc. and Reynolds American Inc. managed to keep their similar products on the market. This was why business observers first thought that Juul would also get the same clearance.
With the imminent announcement of the ban from the FDA, it was said that Juul may pursue an appeal. The company may either challenge the agency’s decision in court or file a revised application for its product lines.
Meanwhile, Reuters reported that shares of Altria Group Inc. tobacco company, the parent of Juul, slid down by eight percent in morning trading following the reports of the FDA’s possible ban decision, which could be handed down this week.
